Identification Keratin 1 as a cDDP-resistant protein in nasopharyngeal carcinoma cell lines

J Proteomics. 2012 Apr 18;75(8):2352-60. doi: 10.1016/j.jprot.2012.02.003. Epub 2012 Feb 12.

Abstract

Multidrug resistance (MDR) to anticancer drugs is a major obstacle to successful chemotherapy of tumors. Understanding the molecular basis to chemoresistance is likely to provide better treatment. Cell lines resistant to cis-diamminedichloroplatinum (CNE2/cDDP) were established from human nasopharyngeal carcinoma (NPC) cell lines CNE2. Comparative proteomics involving 2-dimensional gel electrophoresis (2-DE) and ESI-Q-TOF-MS were performed on protein extracted from CNE2 and CNE2/cDDP cell lines to screen drug resistance-related proteins. Keratin 1 (KRT1), cathepsin D (CTSD) and annexin a5 (ANXA5) were identified as three proteins showing higher expression in CNE2/cDDP compared to CNE2. Furthermore, suppression of KRT1 expression by siRNA resulted in decreased MDR in siRNA-CNE2/cDDP cells. And upregulation of KRT1 could result in increased of drug resistance in NPC cell lines. Taken together, KRT1 protein and its activity levels were higher in cDDP-resistant NPC cell lines compared to their parental cell lines. These data clearly linked KRT1 and cDDP resistance mechanisms. KRT1 could serve as a biomarker for chemotherapy sensitivity of NPC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor / antagonists & inhibitors
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism
  • Carcinoma
  • Cell Line, Tumor
  • Cisplatin / pharmacology
  • Cisplatin / therapeutic use*
  • Drug Evaluation, Preclinical
  • Drug Resistance, Neoplasm* / genetics
  • Drug Resistance, Neoplasm* / physiology
  • Electrophoresis, Gel, Two-Dimensional
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Keratin-1 / antagonists & inhibitors
  • Keratin-1 / genetics
  • Keratin-1 / metabolism
  • Keratin-1 / physiology*
  • Mass Spectrometry
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Neoplasms / drug therapy*
  • Nasopharyngeal Neoplasms / genetics
  • Nasopharyngeal Neoplasms / metabolism*
  • RNA, Small Interfering / pharmacology
  • Transfection
  • Validation Studies as Topic

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • KRT1 protein, human
  • Keratin-1
  • RNA, Small Interfering
  • Cisplatin